Latest News About - Haematology and pathology devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, March 28, 2017

3:53:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Richard Pazdur said: "Maintenance therapy is an important part of a cancer treatment regimen for patients who have responded positively to a primary treatment," External link

prnewswire Monday, March 27, 2017 10:46:00 PM CEST

Bruce Carlson said: "When there's cost cutting elsewhere in healthcare, you see the laboratory become more useful. " External link

prnewswire Monday, March 27, 2017 5:43:00 PM CEST

Johnny Ludvigsson says: "Over the course of the entire trial period the diabetes vaccine, which in this trial was given subcutaneously in combination with vitamin D and ibuprofen, did not show an improvement in the effects of earlier studies with Diamyd. The positive effect seen between 6 and 15 months has endured and has become significant at 30 months when looking at the difference in decline of the endogenous insulin-producing ability compared to placebo. This is really positive and something that we will further analyze in detail," External link

4-traders Monday, March 27, 2017 4:04:00 PM CEST

Mads Krogsgaard said: "The launch of Fiasp® in Canada represents the first new mealtime insulin in 10 years. We hope to make this innovation available to as many people with diabetes as possible worldwide," External link

friedlnews Monday, March 27, 2017 10:04:00 AM CEST

Mads Krogsgaard Thomsen said: "The launch of Fiasp® in Canada represents the first new mealtime insulin in 10 years. We hope to make this innovation available to as many people with diabetes as possible worldwide," External link

friedlnews Monday, March 27, 2017 10:04:00 AM CEST

Mads Krogsgaard said: "The launch of Fiasp® in Canada represents the first new mealtime insulin in 10 years. We hope to make this innovation available to as many people with diabetes as possible worldwide," External link

ots Monday, March 27, 2017 9:17:00 AM CEST

Mads Krogsgaard Thomsen said: "The launch of Fiasp® in Canada represents the first new mealtime insulin in 10 years. We hope to make this innovation available to as many people with diabetes as possible worldwide," External link

ots Monday, March 27, 2017 9:17:00 AM CEST

Mark Miller said: “In the interest of patient safety, it is premature to reach a conclusion regarding the cause,” External link

latimes Thursday, March 23, 2017 5:45:00 PM CET

Peter Horby says: “I think this really was more than an outbreak,” External link

timeshighereducation Thursday, March 23, 2017 1:21:00 AM CET

Peter Horby says: “It’s difficult to gain consent when you’re wearing an Ebola suit and the patients can’t see you and hear you properly,” “Sometimes patients are too unwell to give consent” External link

timeshighereducation Thursday, March 23, 2017 1:21:00 AM CET

Peter Horby points out: “We were conducting clinical research – intravenous infusions of highly experimental drugs – in a tent with intermittent electricity,” “But it was an amazing experience to have that kind of commitment from people: [to see] the willingness of people to dedicate their time and [risk] their own personal safety to get this done. It was extremely invigorating” External link

timeshighereducation Thursday, March 23, 2017 1:21:00 AM CET

Daniel Anderson said: "This gives us a better understanding of the biology behind fibrosis and potentially a way to modulate that response to prevent the formation of scar tissue around implants," External link

newsmedical Wednesday, March 22, 2017 6:10:00 AM CET

Robert Langer said: "One of the things that is particularly exciting to me is that this is one of the first studies to really examine the fundamentals of how the immune system interacts with implantable biomaterials," External link

newsmedical Wednesday, March 22, 2017 6:10:00 AM CET

Carlos Núñez said: "Having JACC publish this research is incredibly positive, encouraging others to look deeper into the potential benefits of ASV therapy," External link

marketwatch Monday, March 20, 2017 11:34:00 PM CET

Daniel Anderson said: "This gives us a better understanding of the biology behind fibrosis and potentially a way to modulate that response to prevent the formation of scar tissue around implants," External link

marketwatch Monday, March 20, 2017 7:24:00 PM CET

Robert Langer said: "One of the things that is particularly exciting to me is that this is one of the first studies to really examine the fundamentals of how the immune system interacts with implantable biomaterials," External link

marketwatch Monday, March 20, 2017 7:24:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.